227 related articles for article (PubMed ID: 30678869)
21. SIRT1 overexpression is an independent prognosticator for patients with esophageal squamous cell carcinoma.
Ma MC; Chiu TJ; Lu HI; Huang WT; Lo CM; Tien WY; Lan YC; Chen YY; Chen CH; Li SH
J Cardiothorac Surg; 2018 Apr; 13(1):25. PubMed ID: 29636061
[TBL] [Abstract][Full Text] [Related]
22. The Prognostic Significance of Histone Demethylase UTX in Esophageal Squamous Cell Carcinoma.
Li SH; Lu HI; Huang WT; Tien WY; Lan YC; Lin WC; Tsai HT; Chen CH
Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29351209
[TBL] [Abstract][Full Text] [Related]
23. Tenascin-C, a Prognostic Determinant of Esophageal Squamous Cell Carcinoma.
Yang ZT; Yeo SY; Yin YX; Lin ZH; Lee HM; Xuan YH; Cui Y; Kim SH
PLoS One; 2016; 11(1):e0145807. PubMed ID: 26731558
[TBL] [Abstract][Full Text] [Related]
24. Eukaryotic translation initiation factor 3B accelerates the progression of esophageal squamous cell carcinoma by activating β-catenin signaling pathway.
Xu F; Xu CZ; Gu J; Liu X; Liu R; Huang E; Yuan Y; Zhao G; Jiang J; Xu C; Chu Y; Lu C; Ge D
Oncotarget; 2016 Jul; 7(28):43401-43411. PubMed ID: 27270324
[TBL] [Abstract][Full Text] [Related]
25. Preoperative systemic inflammation score (SIS) is superior to neutrophil to lymphocyte ratio (NLR) as a predicting indicator in patients with esophageal squamous cell carcinoma.
Fu X; Li T; Dai Y; Li J
BMC Cancer; 2019 Jul; 19(1):721. PubMed ID: 31331297
[TBL] [Abstract][Full Text] [Related]
26. Monocarboxylate transporter 1 is an independent prognostic factor in esophageal squamous cell carcinoma.
Chen X; Chen X; Liu F; Yuan Q; Zhang K; Zhou W; Guan S; Wang Y; Mi S; Cheng Y
Oncol Rep; 2019 Apr; 41(4):2529-2539. PubMed ID: 30720131
[TBL] [Abstract][Full Text] [Related]
27. Angiotensin II type I receptor (AT1R) is an independent prognosticator of esophageal squamous cell carcinoma and promotes cells proliferation via mTOR activation.
Li SH; Lu HI; Chang AY; Huang WT; Lin WC; Lee CC; Tien WY; Lan YC; Tsai HT; Chen CH
Oncotarget; 2016 Oct; 7(41):67150-67165. PubMed ID: 27564102
[TBL] [Abstract][Full Text] [Related]
28. Prognostic Significance of Postoperative Complications After Curative Resection for Patients With Esophageal Squamous Cell Carcinoma.
Saeki H; Tsutsumi S; Tajiri H; Yukaya T; Tsutsumi R; Nishimura S; Nakaji Y; Kudou K; Akiyama S; Kasagi Y; Nakanishi R; Nakashima Y; Sugiyama M; Ohgaki K; Sonoda H; Oki E; Maehara Y
Ann Surg; 2017 Mar; 265(3):527-533. PubMed ID: 28169928
[TBL] [Abstract][Full Text] [Related]
29. Comparison Between Esophagectomy and Definitive Chemoradiotherapy in Patients With Esophageal Cancer.
Wang BY; Hung WH; Wu SC; Chen HC; Huang CL; Lin CH; Chen HS
Ann Thorac Surg; 2019 Apr; 107(4):1060-1067. PubMed ID: 30571951
[TBL] [Abstract][Full Text] [Related]
30. Plasma fibrinogen levels are correlated with postoperative distant metastasis and prognosis in esophageal squamous cell carcinoma.
Zhang D; Zhou X; Bao W; Chen Y; Cheng L; Qiu G; Sheng L; Ji Y; Du X
Oncotarget; 2015 Nov; 6(35):38410-20. PubMed ID: 26334098
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of the 7th edition of the TNM classification in patients with resected esophageal squamous cell carcinoma.
Wang J; Wu N; Zheng QF; Yan S; Lv C; Li SL; Yang Y
World J Gastroenterol; 2014 Dec; 20(48):18397-403. PubMed ID: 25561808
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of global histone modifications in resected squamous cell carcinoma of the esophagus.
Tzao C; Tung HJ; Jin JS; Sun GH; Hsu HS; Chen BH; Yu CP; Lee SC
Mod Pathol; 2009 Feb; 22(2):252-60. PubMed ID: 18953329
[TBL] [Abstract][Full Text] [Related]
33. Phosphorylated p70S6K expression is an independent prognosticator for patients with esophageal squamous cell carcinoma.
Li SH; Chen CH; Lu HI; Huang WT; Tien WY; Lan YC; Lee CC; Chen YH; Huang HY; Chang AY; Lin WC
Surgery; 2015 Mar; 157(3):570-80. PubMed ID: 25726316
[TBL] [Abstract][Full Text] [Related]
34. Risk Factors for Local Recurrence and Optimal Length of Esophagectomy in Esophageal Squamous Cell Carcinoma.
Kang CH; Hwang Y; Lee HJ; Park IK; Kim YT
Ann Thorac Surg; 2016 Oct; 102(4):1074-80. PubMed ID: 27302078
[TBL] [Abstract][Full Text] [Related]
35. Sex differences in the prognosis after surgery for esophageal squamous cell carcinoma and adenocarcinoma.
Kauppila JH; Wahlin K; Lagergren P; Lagergren J
Int J Cancer; 2019 Mar; 144(6):1284-1291. PubMed ID: 30168595
[TBL] [Abstract][Full Text] [Related]
36. Effects of Intraoperative Opioid Use on Recurrence-Free and Overall Survival in Patients With Esophageal Adenocarcinoma and Squamous Cell Carcinoma.
Du KN; Feng L; Newhouse A; Mehta J; Lasala J; Mena GE; Hofstetter WL; Cata JP
Anesth Analg; 2018 Jul; 127(1):210-216. PubMed ID: 29757780
[TBL] [Abstract][Full Text] [Related]
37. Prognostic implications of
Kwon D; Yun JY; Keam B; Kim YT; Jeon YK
World J Gastroenterol; 2016 Nov; 22(44):9803-9812. PubMed ID: 27956804
[TBL] [Abstract][Full Text] [Related]
38. PRAF2 overexpression predicts poor prognosis and promotes tumorigenesis in esophageal squamous cell carcinoma.
Qian Z; Wei B; Zhou Y; Wang Q; Wang J; Sun Y; Gao Y; Chen X
BMC Cancer; 2019 Jun; 19(1):585. PubMed ID: 31200670
[TBL] [Abstract][Full Text] [Related]
39. Increased MET gene copy number negatively affects the survival of esophageal squamous cell carcinoma patients.
Wang Y; Jiang Z; Xu C; Wang H; Tan L; Su J; Wang X; Jiang D; Hou Y; Song Q
BMC Cancer; 2019 Mar; 19(1):240. PubMed ID: 30885149
[TBL] [Abstract][Full Text] [Related]
40. Downregulation of SIRT4 Expression Is Associated with Poor Prognosis in Esophageal Squamous Cell Carcinoma.
Nakahara Y; Yamasaki M; Sawada G; Miyazaki Y; Makino T; Takahashi T; Kurokawa Y; Nakajima K; Takiguchi S; Mimori K; Mori M; Doki Y
Oncology; 2016; 90(6):347-55. PubMed ID: 27082627
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
